Today's Daily Dose brings you news about Pfizer/BioNTech's COVID-19 vaccine trial results; Blueprint's submission of Pralsetinib NDA; reverse merger of MedAvail with MYOS; Liminal BioSciences' efforts to fight the ongoing pandemic and upsized public offering of AdaptHealth.
from RTT - Biotech https://ift.tt/3eTpAls
via IFTTT
No comments:
Post a Comment